Novel drug shows success for previously incurable advanced pulmonary hypertension
Pulmonary arterial hypertension (PAH) is a rare form of pulmonary hypertension. It occurs because progressive vascular ...
Verywell Health on MSN10d
7 Common Causes of Pulmonary Arterial Hypertension
Pulmonary arterial hypertension is caused by narrowing of the blood vessels in the lungs. Learn how it happens, including ...
Hypertension Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies
In April 2025, Actelion announced a study is to demonstrate superiority of macitentan 75 milligrams (mg) in prolonging the ...
Healthshots on MSN8mon
Pulmonary hypertension affects your heart and lung function: Tips to manage it
Pulmonary hypertension (PH) is a serious condition ... get regular health checkups to diagnose the condition at an early ...
Pulmonary Hypertension News3d
Phaware podcast series to shine light on advancements in PH-ILD
New podcasts from advocacy organization Phaware will highlight treatment advances in pulmonary hypertension tied to ...
MedPage Today on MSN6d
Sotatercept Helps the Sickest Patients With Pulmonary Arterial Hypertension
CHICAGO -- Adding sotatercept (Winrevair) to the treatment regimen for pulmonary arterial hypertension (PAH) in high-risk ...
The New England Journal of Medicine8d
Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for Death
Sotatercept improves exercise capacity and delays the time to clinical worsening in patients with World Health Organization (WHO) functional class II or III pulmonary arterial hypertension.
Managed Healthcare Executive7d
Winrevair Shows Promise in Advancing PAH Treatment | ACC 2025
Marc Humbert, M.D., Ph.D., professor of respiratory medicine at Université Paris-Saclay and Inserm, believes that recent ...
Hosted on MSN2mon
Tectonic jumps on positive data from early-stage trial for lead asset
The open-label study enrolled those with Group 2 pulmonary hypertension in heart failure with preserved ejection fraction (“PH-HFpEF”) and heart failure with reduced ejection fraction (“PH ...